In contrast, mounting evidence from in vivo studies suggests functional and cellular signalling roles for TG2 in cardiac tissue remodelling processes and their dysregulation in myocardial hypertrophy and infarction and heart failure, among other cardiac diseases [17, 19, 44–46]. Here, TGM2 is linked to cardiac hypertrophy.